“The More Original A Discovery, The More Obvious It Seems Afterwards”
- Authur Koestler
Cutting Edge Research Primed For ROI
EndoProtech is a Delaware company. It was founded in 2004 by Claudio Maldonado, Gustavo Perez-Abadia and Federico Grossi. To date, EndoProtech’s innovative therapies have been developed and funded with six Federal Phase I and Phase II SBIR grant awards from the National Institutes of Health. The company’s patent portfolio includes an awarded platform technology patent, and two pending therapy patents. EndoProtech is starting the FDA regulatory process
If you are interested in joining a winning venture please contact us.